238 related articles for article (PubMed ID: 16732330)
1. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.
Benzeno S; Lu F; Guo M; Barbash O; Zhang F; Herman JG; Klein PS; Rustgi A; Diehl JA
Oncogene; 2006 Oct; 25(47):6291-303. PubMed ID: 16732330
[TBL] [Abstract][Full Text] [Related]
2. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
Lu F; Gladden AB; Diehl JA
Cancer Res; 2003 Nov; 63(21):7056-61. PubMed ID: 14612495
[TBL] [Abstract][Full Text] [Related]
3. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer.
Barbash O; Zamfirova P; Lin DI; Chen X; Yang K; Nakagawa H; Lu F; Rustgi AK; Diehl JA
Cancer Cell; 2008 Jul; 14(1):68-78. PubMed ID: 18598945
[TBL] [Abstract][Full Text] [Related]
4. p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export.
Alt JR; Gladden AB; Diehl JA
J Biol Chem; 2002 Mar; 277(10):8517-23. PubMed ID: 11751903
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.
Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW
BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation.
Alt JR; Cleveland JL; Hannink M; Diehl JA
Genes Dev; 2000 Dec; 14(24):3102-14. PubMed ID: 11124803
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
Masamha CP; Benbrook DM
Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells.
Wei S; Yang HC; Chuang HC; Yang J; Kulp SK; Lu PJ; Lai MD; Chen CS
J Biol Chem; 2008 Sep; 283(39):26759-70. PubMed ID: 18650423
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B Virus X Protein Stabilizes Cyclin D1 and Increases Cyclin D1 Nuclear Accumulation through ERK-Mediated Inactivation of GSK-3β.
Chen X; Zhang L; Zheng S; Zhang T; Li M; Zhang X; Zeng Z; McCrae MA; Zhao J; Zhuang H; Lu F
Cancer Prev Res (Phila); 2015 May; 8(5):455-63. PubMed ID: 25712050
[TBL] [Abstract][Full Text] [Related]
11. The involvement of cyclin D1 degradation through GSK3β-mediated threonine-286 phosphorylation-dependent nuclear export in anti-cancer activity of mulberry root bark extracts.
Eo HJ; Park GH; Jeong JB
Phytomedicine; 2016 Feb; 23(2):105-13. PubMed ID: 26926171
[TBL] [Abstract][Full Text] [Related]
12. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity.
Ramljak D; Calvert RJ; Wiesenfeld PW; Diwan BA; Catipovic B; Marasas WF; Victor TC; Anderson LM; Gelderblom WC
Carcinogenesis; 2000 Aug; 21(8):1537-46. PubMed ID: 10910956
[TBL] [Abstract][Full Text] [Related]
13. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
[TBL] [Abstract][Full Text] [Related]
14. C-terminal sequences direct cyclin D1-CRM1 binding.
Benzeno S; Diehl JA
J Biol Chem; 2004 Dec; 279(53):56061-6. PubMed ID: 15513923
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
[TBL] [Abstract][Full Text] [Related]
16. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase-->AKT-->GSK-3beta-->cyclin D1-->pRB pathway to block uterine epithelial cell proliferation.
Chen B; Pan H; Zhu L; Deng Y; Pollard JW
Mol Endocrinol; 2005 Aug; 19(8):1978-90. PubMed ID: 15845746
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.
Solomon DA; Wang Y; Fox SR; Lambeck TC; Giesting S; Lan Z; Senderowicz AM; Conti CJ; Knudsen ES
J Biol Chem; 2003 Aug; 278(32):30339-47. PubMed ID: 12746453
[TBL] [Abstract][Full Text] [Related]
19. CDK4 protein is degraded by anaphase-promoting complex/cyclosome in mitosis and reaccumulates in early G
Chen H; Xu X; Wang G; Zhang B; Wang G; Xin G; Liu J; Jiang Q; Zhang H; Zhang C
J Biol Chem; 2017 Jun; 292(24):10131-10141. PubMed ID: 28446612
[TBL] [Abstract][Full Text] [Related]
20. GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma.
Dal Col J; Dolcetti R
Cell Cycle; 2008 Sep; 7(18):2813-6. PubMed ID: 18769147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
